Grazoprevir is a pharmaceutical raw material used in the manufacturing of antiviral products. It acts as an inhibitor of the Hepatitis C virus NS3/4A protease and also exhibits inhibitory activity against breast cancer resistance protein and cytochrome P450 3A.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1350514-68-9
Grazoprevir monohydrate
pharmaceutical raw material
Repaglinide
pharmaceutical raw material
Lefamulin acetate
pharmaceutical raw material
Vericiguat
pharmaceutical raw material
Ceralasertib
pharmaceutical raw material
Voxilaprevir
pharmaceutical raw material
(1R,18R,20R,24S,27S)-24-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo[24.2.1.03,12.05,10.018,20]nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide
OBMNJSNZOWALQB-NCQNOWPTSA-N
CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCC[C@@H]7C[C@H]7OC(=O)N1